Company / Depreciation & Amortization
Evolent Health, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$115.9M
FY2025
5-year range
$60.0M / $123.4M
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $17M in FY2016 to $123M in FY2023.
Based on SEC 10-K filings.
$116M in FY2025 with a 5-year CAGR of +13.5%.
Improved from $123M to $116M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 2.1% year-over-year.
- Peak depreciation & amortization was recorded in FY2023.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $115.9M | -2.1% |
| FY2024 | $118.4M | -4.1% |
| FY2023 | $123.4M | +83.7% |
| FY2022 | $67.2M | +11.9% |
| FY2021 | $60.0M | -2.3% |
| FY2020 | $61.5M | +0.9% |
| FY2019 | $60.9M | +36.8% |
| FY2018 | $44.5M | +37.5% |
| FY2017 | $32.4M | +87.9% |
| FY2016 | $17.2M | +140.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026